ELDN · NASDAQ · Biotechnology

Eledon Pharmaceuticals (ELDN)

Develops tegoprubart for transplant rejection and CD40L-linked immune disease.

$3.06
Pre-market+0.08 (+2.51%)
At close$2.99(−0.83%)

Breakdown13F · 13D/G · Form 4

Institutions168 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail≈ 57.56%46.77M shares
Insiders10 holders · as of Aug 4, 20261.30%1.06M shares
Otherremainder≈ 41.14%33.43M shares

81.26M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
BVF Inc/ILInstitution
7.74%6.29M13Fas of Jun 30, 2026
Biotechnology Value Fund L PInstitution
6.62%5.38M13Gfiled May 15, 2026
BlackRock, Inc.Institution
6.31%5.12M13Fas of Jun 30, 2026
Defilade Capital Management, L.P.Institution
4.34%3.53M13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.21%3.42M13Fas of Jun 30, 2026
Goldman Sachs Group IncInstitution
3.09%2.51M13Fas of Jun 30, 2026
Ensign Peak Advisors, IncInstitution
2.59%2.10M13Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.41%1.96M13Fas of Jun 30, 2026
Catalio Capital Management, LPInstitution
2.09%1.70M13Fas of Jun 30, 2026
State Street CorpInstitution
2.00%1.62M13Fas of Jun 30, 2026
Zimmer Partners, LPInstitution
1.96%1.60M13Fas of Jun 30, 2026
Sphera Funds Management Ltd.Institution
1.47%1.19M13Fas of Jun 30, 2026
Awm Investment Company, Inc.Institution
1.35%1.10M13Fas of Jun 30, 2026
UBS Group AGInstitution
1.29%1.05M13Fas of Jun 30, 2026
Kingdon Capital Management, L.L.C.Institution
1.28%1.04M13Fas of Jun 30, 2026
Millennium Management LLCInstitution
1.21%979,71213Fas of Jun 30, 2026
Bank of America Corp /DE/Institution
1.09%883,09713Fas of Jun 30, 2026
Adar1 Capital Management, LLCInstitution
0.80%647,81213Fas of Jun 30, 2026
22NW, LPInstitution
0.78%636,36413Fas of Jun 30, 2026
Northern Trust CorpInstitution
0.76%616,39913Fas of Jun 30, 2026
AQR Capital Management LLCInstitution
0.72%581,02813Fas of Jun 30, 2026
CM Management, LLCInstitution
0.71%575,00013Fas of Jun 30, 2026
Blue Owl Capital Holdings LPInstitution
0.70%566,50913Fas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
0.66%538,73813Fas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
0.66%533,36513Fas of Jun 30, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Jun 30, 2026

168 holders · 46.77M shares · 50 new positions · 113 increased · 23 reduced · 11 closed

HolderShares% outstandingChg q/qFiled
BVF Inc/IL6.29M7.74%0Aug 14, 2026
BlackRock, Inc.5.12M6.31%+741.6KAug 7, 2026
Defilade Capital Management, L.P.3.53M4.34%−38.8KAug 14, 2026
Vanguard Capital Management LLC3.42M4.21%+124.1KAug 13, 2026
Goldman Sachs Group Inc2.51M3.09%+2.14MAug 14, 2026
Ensign Peak Advisors, Inc2.10M2.59%−363.7KAug 14, 2026
Geode Capital Management, LLC1.96M2.41%+164.8KAug 12, 2026
Catalio Capital Management, LP1.70M2.09%+55.3KAug 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Biotechnology Value Fund L P6.80%5.38M13GMay 15, 2026
Patrick J. Heronincl. Fhmls Xi, L.L.C., Frazier Life Sciences X, L.P. +14 more6.10%3.56M13GNov 5, 2024
RA Capital Healthcare Fund, L.P.incl. RA Capital Management, L.P., Rajeev Shah +1 more6.10%3.57M13GNov 5, 2024
BlackRock, Inc.5.80%4.38M13GApr 27, 2026
Vanguard Capital Management5.05%3.90M13GJul 31, 2026

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.